Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.
Ibarra M, Combs R, Taylor ZL, Ramsey LB, Mikkelsen T, Buddington RK, Heldrup J, Barreto JN, Guscott M, Lowe J, Hurmiz C, Marada S, Howard SC, Schaiquevich P.
Ibarra M, et al. Among authors: heldrup j.
Br J Clin Pharmacol. 2023 Feb;89(2):660-671. doi: 10.1111/bcp.15506. Epub 2022 Sep 11.
Br J Clin Pharmacol. 2023.
PMID: 35998099
Free article.